Affordable Access

The PD-1/PD-L1 pathway in human pathology.

Authors
  • Saresella, M
  • Rainone, V
  • Al-Daghri, N M
  • Clerici, M
  • Trabattoni, D
Type
Published Article
Journal
Current Molecular Medicine
Publisher
Bentham Science
Publication Date
Mar 01, 2012
Volume
12
Issue
3
Pages
259–267
Identifiers
PMID: 22300137
Source
Medline
License
Unknown

Abstract

T-cell activation is dependent on signals delivered through the antigen-specific T-cell receptor and accessory receptors on T-cells. Integration of signals through this family of costimulatory and inhibitory receptors and their ligands regulates the balance between T-cell activation, tolerance, and immunopathology. Programmed death 1 (PD-1) and its ligands, PD-L1 and PD-L2, deliver inhibitory signals and exert a vital and diverse range of immunoregulatory roles in T-cell activation, tolerance, and immune-mediated tissue damage. In this review, we revisit current understanding of the immunoregulatory functions of PD-1 and its ligands and their involvement in immune-mediated diseases.

Report this publication

Statistics

Seen <100 times